EUROPEAN SOCIETY FOR ORGAN TRANSPLANTATION

ESOT 2021 Recordings

 

Aug 29 - Sept 1, 2021 Milano
Close
N. Poster
Poster title
Applicant name
Status
  3-LDV ENHANCED DELIVERY OF NANOMEDICINE TO KIDNEY GRAFT ENDOTHELIAL CELLS DURING EX VIVO PERFUSION Claire ALBERT Received Received
  3-OP CRISPR-CAS9 HLA-DELETED GLOMERULAR ENDOTHELIAL CELLS AS A TOOL TO DETECT PATHOGENIC NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS Baptiste Lamarthée Received Received
  6-OP TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODY-MEDIATED REJECTION Gesa Tiller Received Received
  7-OP CD56DIM CD16BRIGHT NK CELLS DURING ANTIBODY-MEDIATED REJECTION DISPLAY INCREASED PROLIFERATION, ACTIVATION AND TYPE-1 INFLAMMATORY CYTOTOXIC PROFILES Elodie Bailly Received Received
  9-OP WATERLOW SCORE ON ADMISSION AND POST-SURGERY RISK OF PROLONGED LENGTH OF STAY, EMERGENCY READMISSION AND MORTALITY RISK Anna Brotherton Received Received
  10-OP FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Evelien Quint Received Received
  11-OP ASSESSING RISK FACTORS OF NON-ADHERENCE AND POST-TRANSPLANT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS Kateryna Maksyutynska Received Received
  12-OP IMPACT OF THE COVID-19 PANDEMIC ON DAILY LIVES, EMOTIONS AND BEHAVIOURS OF KIDNEY TRANSPLANT RECIPIENTS Regina Van Zanten Received Received
  13-OP SOCIAL DISTRESS AND HEALTH-RELATED QUALITY OF LIFE IN SOLID ORGAN TRANSPLANT RECIPIENTS Noor Al Kaabi Received Received
  14-OP RENAL TRANSPLANT OUTCOMES IN YOUNG ADULTS BEFORE AND AFTER THE INTRODUCTION OF A YOUNG ADULT SERVICE Laura Baines Received Received
  15-OP SUPPORTING TEENAGE AND YOUNG ADULT TRANSPLANT RECIPIENTS DURING COVID-19 PANDEMIC USING A SOCIAL MEDIA PATIENT GROUP Daley Cross Received Received
  16-OP SHORT- AND LONG-TERM PREGNANCY OUTCOMES AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN THE NETHERLANDS Jildau Meinderts Received Received
  17-OP FATIGUE AMONG HEART RECIPIENTS- A BARRIER TO SELF-EFFICACY? Matilda Almgren Received Received
  18-OP SYMPTOM OCCURRENCE AND DISTRESS AFTER HEART TRANSPLANTATION - A NATIONWIDE CROSS-SECTIONAL COHORT STUDY. Marita Dalvindt Received Received
  19-OP RECOVERY AND SELF-EFFICACY AFTER HEART TRANSPLANTATION- IMPORTANT ASPECTS OF SELF-MANAGEMENT Matilda Almgren Received Received
  20-OP THE MEANING OF SURVIVING THREE YEARS AFTER A HEART TRANSPLANT - A TRANSITION FROM UNCERTAINTY TO ACCEPTANCE THROUGH ADAPTATION Anna Forsberg Received Received
  21-OP FATIGUE, SELF-EFFICACY AND RECOVERY 1-5 YEARS AFTER LUNG TRANSPLANTATION Annette Lennerling Received Received
  22-OP ADAPTATION AFTER LUNG TRANSPLANTATION UP TO THREE YEARS AFTER TRANSPLANTATION. Martina Lundmark Received Received
  23-OP OUTCOME OF LIVER TRANSPLANTATION FOR NON-HCC MALIGNANCIES – A COLLABORATIVE TRANSPLANT STUDY REPORT Philipp Houben Received Received
  25-OP DIFFERENT PATTERNS OF RECURRENCE AFTER LIVER RESECTION AND TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS Jorgelina Coppa Received Received
  26-OP LONG TERM OUTCOMES AFTER LIVER TRANSPLANTATION VERSUS RESECTION FOR MILAN-IN NEUROENDOCRINE TUMOR LIVER METASTASES Marianna Maspero Received Received
  27-OP UNRESECTABLE GASTROINTESTINAL STROMAL TUMOR (GIST) LIVER METASTASES AS A NEW INDICATION FOR LIVER TRANSPLANTATION. HAS ITS TIME ARRIVED? Felipe Alconchel Received Received
  31-OP EVOLUTION OF PATIENTS WITH DEVASTATING BRAIN INJURY ADMITTED IN INTENSIVE CARE UNIT FOR INTENSIVE CARE TO FACILITATE ORGAN DONATION Alicia Perez Received Received
  32-OP PERCEIVED AND VERIFIED CANCER HISTORY IN POTENTIAL SOLID ORGAN DONORS: AN AUSTRALIAN COHORT STUDY James Hedley Received Received
  34-OP THE ROLE OF THE SURGICAL CARE PRACTITIONER IN ORGAN RETRIEVAL: A SINGLE-CENTRE EXPERIENCE Francesco Abbadessa Received Received
  35-OP ASSESSMENT OF DONOR-RECIPIENT SIZE MISMATCH BASED ON BODY SURFACE AREA INDEX AND ITS IMPLICATIONS ON OUTCOMES OF DECEASED-DONOR LIVER TRANSPLANTS Ioannis D. Kostakis Received Received
  38-OP FACING THE CHALLENGE: TRANSPLANT ACCESS FOR THE HIGHEST SENSITIZED PATIENTS (CPRA=100%). THE SPANISH EXPERIENCE Maria O Valentin Received Received
  39-OP IMPACT OF INHIBITION OF PCSK-9 AMONG RENAL TRANSPLANT RECIPIENTS WITH HIGH CARDIOVASCULAR RISK Osama Gheith Received Received
  40-OP IMPACT OF FULL CORRECTION OF POST-TRANSPLANT ANEMIA ON CARDIOVASCULAR SYSTEM IN RENAL TRANSPLANT RECIPIENTS RECEIVING ESA: PROSPECTIVE RCT Ayman Maher Nagib Received Received
  41-OP IS ERYTHROCYTOSIS MORE FREQUENT AFTER SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION?: A SINGLE-CENTER EXPERIENCE Marina Reis Received Received
  42-OP COMPARING SURVIVAL OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS WITH PRE-EXISTING DIABETES VERSUS THOSE WHO DEVELOP POST-TRANSPLANTATION DIABETES Azm Hussain Received Received
  43-OP OUTCOMES OF SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES Tarek Mahmoud Received Received
  44-OP HLA ALLELES CW12 AND DQ4 IN KIDNEY TRANSPLANT RECIPIENTS ARE INDEPENDENT RISK FACTORS FOR THE DEVELOPMENT OF POST-TRANSPLANTATION DIABETES Azm Hussain Received Received
  45-OP SEMAGLUTIDE IS A SAFE AND EFFECTIVE TREATMENT IN PATIENTS AFTER LIVER TRANSPLANTATION WITH POST-TRANSPLANT DIABETES MELLITUS Maarten Tushuizen Received Received
  46-OP DETERMINATS OF THE APPERANANCE OF POST TRANSPLANT DIABETES MELLITUS AFTER KINDEY TRASNAPLANTION Maria Smyrli Received Received
  47-OP AMPUTATION AND ULCERATION IN TYPE-1 DIABETIC PATIENTS UNDERGOING SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION: A SYSTEMATIC REVIEW Jineel Raythatha Received Received
  48-OP EVEROLIMUS, GLUCOSE METABOLISM, AND ANTI- VISCERAL OBESITY EFFECT IN KIDNEY TRANSPLANT CANDIDATES Mikiko Yoshikawa Received Received
  49-OP OUTCOMES OF LIVER TRANSPLANTS FOR NASH FROM A LARGE SINGLE INSTITUTIONAL COHORT Aamir Nawaz Received Received
  50-OP VARIATIONS IN TM6SF2 RS58542926, PCSK9 RS505151 AND PCSK7 RS2277287 WITH THE RISK OF HEPATIC STEATOSIS AFTER LIVER TRANSPLANTATION Ahad Eshraghian Received Received
  51-OP IMPACT OF ELECTIVE LIGATION OF A PATENT ARTERIOVENOUS FISTULA IN KIDNEY TRANSPLANT RECIPIENTS ON BLOOD PRESSURE AND SERUM LEVELS OF CARDIAC BIOMARKERS Gregoire Masson Received Received
  52-OP POSITIVE IMPACT OF KIDNEY TRANSPLANTATION ON OLFACTORY ABILITY: RESULTS OF A CROSS-SECTIONAL CASE CONTROL STUDY. Chiara Caletti Received Received
  53-OP IMPACT OF FCGR3A POLYMORPHISMS ON AMR OUTCOME AND IVIG RESPONSE IN KIDNEY TRANSPLANT RECIPIENTS Alice Koenig Received Received
  54-OP THE FCGR3A-158 V/V-GENOTYPE IS ASSOCIATED WITH DECREASED SURVIVAL OF RENAL ALLOGRAFTS WITH CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION Nicolle Litjens Received Received
  55-OP PREFORMED T-CELL ALLOIMMUNITY AND HLA EPLET MISMATCH TO GUIDE IMMUNOSUPPRESSION MINIMIZATION WITH TACROLIMUS MONOTHERAPY IN KIDNEY TRANSPLANTATION. Maria Meneghini Received Received
  56-OP HLA EPITOPE MISMATCHES IN KIDNEY TRANSPLANT RECIPIENTS WITH HISTOLOGICAL ANTIBODY-MEDIATED REJECTION WITH AND WITHOUT HLA DONOR-SPECIFIC ANTIBODIES Laura Llinàs-Mallol Received Received
  57-OP UNSUPERVISED MACHINE LEARNING IDENTIFIES FAST AND SLOW MODULATION OF DSA DYNAMICS FOLLOWING HLA- INCOMPATIBLE TRANSPLANTATION – 5 YEAR OUTCOMES. Sunil Daga Received Received
  58-OP MYELOID-DERIVED SUPPRESSOR CELLS IN KIDNEY TRANSPLANT RECIPIENTS AND THE EFFECT OF MAINTENANCE IMMUNOTHERAPY Maria Iglesias Escudero Received Received
  59-OP CLINICAL VALUE OF THE USE OF COMPLETE HIGH RESOLUTION HLA TYPING FOR THE DEFINITION OF DNDSA AFTER KIDNEY TRANSPLANTATION Maria Meneghini Received Received
  60-OP DONOR-SPECIFIC ELISPOT ASSAY FOR PREDICTING ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Suwasin Udomkarnjananun Received Received
  61-OP HLA AND NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH A HISTOLOGICAL PICTURE OF ANTIBODY-MEDIATED REJECTION Laura Llinàs-Mallol Received Received
  62-OP DEVELOPMENT OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AND ABMR IN RENAL TRANSPLANT PATIENTS DEPENDS ON CYP3A5 GENOTYPE Justa Friebus-Kardash Received Received
  63-OP EVOLUTION OF HUMORAL LESIONS ON CONTROL BIOPSY STRATIFIES THE RISK FOR RENAL GRAFT LOSS AFTER ANTIBODY-MEDIATED REJECTION TREATMENT Antonin Bouchet Received Received
  64-OP CHALLENGING EARLY CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION AFTER SUCCESSFUL DESENSITIZATION FOR CDC-CROSSMATCH-POSITIVE KIDNEY TRANSPLANTION. Annelies De Weerd Received Received
  65-OP TEMRA CD8 T CELLS FROM KIDNEY TRANSPLANT RECIPIENTS EXHIBIT ENHANCED PURINERGIC P2X4 RECEPTOR-DEPENDENT PROINFLAMMATORY AND MIGRATORY RESPONSES Nicolas Degauque Received Received
  66-OP GRANZYME B POSITIVE B CELLS ENRICH REGULATORY T CELL COMPARTMENT AND INDUCE INHIBITION OF EFFECTOR CD4+ CD25- T CELL RESPONSE. Nicolas Sailliet Received Received
  67-OP THE IMPACT OF DONOR AND RECIPIENT SIZE IN PAEDIATRIC RENAL TRANSPLANTATION Ioannis D. Kostakis Received Received
  68-OP UK CONSENSUS ON SURGICAL TECHNIQUES IN PAEDIATRIC RENAL TRANSPLANT John Fallon Received Received
  69-OP IMPACT OF VASCULAR ANOMALIES ON SURGICAL COMPLICATIONS AND OUTCOME IN PEDIATRIC KIDNEY TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER ANALYSIS. Gionata Spagnoletti Received Received
  70-OP FINAL HEIGHT OF CHILDREN OVER 12 YEARS INITIATED ON A STEROID MINIMISATION IMMUNOSUPPRESSIVE REGIMEN FOLLOWING KIDNEY TRANSPLANTATION Demetria Theodorou Received Received
  71-OP IMPACT OF DONOR HUMAN LEUKOCYTE ANTIGEN SPECIFIC ANTIBODIES DETECTED IN PEDIATRIC KIDNEY TRANSPLANT PATIENTS WITH STABLE OR DECLINED GRAFT FUNCTION Asimina Fylaktou Received Received
  73-OP STANDARDISATION OF IMMUNOSUPPRESSIVE AND ANTI-INFECTIVE DRUG REGIMENS IN UK PAEDIATRIC RENAL TRANSPLANTATION: THE HARMONISATION PROGRAMME Stephen D Marks Received Received
  74-OP KIDNEY TRANSPLANTED CHILDREN NOT RESPONDING TO ANTI-REJECTION TREATMENT: HOW TO IMPROVE THE OUTCOME Irene Alberici Received Received
  77-OP LUNG TRANSPLANT FOR PULMONARY FIBROSIS; SMALLER DONOR LUNGS IMPACT SURVIVAL Gillian Hardman Received Received
  81-OP DONOR LYMPHOCYTES IN PERIPHERAL BLOOD OF PATIENTS AFTER LUNG TRANSPLANTATION COMPRISE HIGH FREQUENCIES OF KIR-POSITIVE T AND NK CELL SUBSETS Jenny Kuehne Received Received
  82-OP MIR-339 AND GALECTIN-3: DIAGNOSTIC VALUE IN PATIENTS WITH AIRWAY OBSTRUCTION AFTER LUNG TRANSPLANTATION Olga Gichkun Received Received
  86-OP MONITORING OF ANTIVIRAL IMMUNE RESPONSE AS AN INDICATOR OF IMMUNOSUPPRESSION INTENSITY AND OUTCOME AFTER KIDNEY TRANSPLANTATION: THE VIRENO STUDY Veronica Di Cristanziano Received Received
  87-OP LUMINAL ACTIVATION OF COMPLEMENT WITH APICAL DEPOSITION OF C3DG AND C5B-9 IN THE PROXIMAL TUBULES IN KIDNEY TRANSPLANT RECIPIENTS Gustaf Isaksson Received Received
  88-OP THE UPTAKE OF THE PET RADIOTRACER 18-FLUORODEOXYGLUCOSE BY THE RENAL ALLOGRAFT CORRELATES WITH THE ACUTE BANFF SCORES OF CORTEX INFLAMMATION Francois Jouret Received Received
  91-OP OBSERVATIONS ON 24-HOUR EX SITU NORMOTHERMIC LIVER PERFUSION Amelia Hessheimer Received Received
  95-OP ASSOCIATION OF PROCUREMENT TIME WITH SHORT- AND LONG-TERM OUTCOMES AFTER LIVER TRANSPLANTATION Verner Eerola Received Received
  96-OP HEPATITIS B OCCULT INFECTION IN DECEASED LIVER DONORS: LONG TERM POST TRANSPLANT CLINICAL EVALUATION. Davide Cussa Received Received
  97-OP PROPOSAL AND VALIDATION OF A LIVER GRAFT DISCARD SCORE FOR LIVER TRANSPLANTATION: A MULTICENTRE ITALIAN STUDY Fabio Melandro Received Received
  98-OP EXTENDED CRITERIA DONORS IN LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Francesco Giovinazzo Received Received
  99-OP DONATION AFTER CIRCULATORY DEATH LIVERS CAN BE SAFELY USED FOR TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING PORTAL VEIN THROMBOSIS Willemijn Van Der Plas Received Received
  100-OP RISK FACTORS ASSOCIATED WITH HISTOLOGICAL INJURY TO THE DEEP PERIBILIARY GLANDS AND PERIBILIARY VASCULAR PLEXUS PRIOR TO LIVER TRANSPLANTATION Willemijn Van Der Plas Received Received
  101-OP INDICATIONS AND WAITING LIST PRIORITY FOR DECEASED DONOR LIVER TRANSPLANTATION IN HIV/HCV CO-INFECTED PATIENTS IN JAPAN. Susumu Eguchi Received Received
  102-OP RECENT TRENDS AND INTENTION-TO-TREAT SURVIVAL OF LIVER TRANSPLANTATION FOR NONALCOHOLIC STEATOHEPATITIS:AN ITALIAN LIVER TRANSPLANT REGISTRY STUDY Chiara Di Renzo Received Received
  103-OP OUTCOMES OF DONORS WITH BMI=30 FOR LIVING DONOR LIVER TRANSPLANTATION Oya Andacoglu Received Received
  104-OP PERFORMANCE OF ARTIFICIAL INTELLIGENCE IN PREDICTING SURVIVAL FOLLOWING LIVER TRANSPLANTATION: STUDY USING DATA FROM THE KOREAN TRANSPLANT REGISTRY Young-Dong Yu Received Received
  105-OP UPDATE ON WAITLIST MORTALITY OF YOUNG PATIENTS WITH BILIARY ATRESIA - RESULTS FROM THE EUROTRANSPLANT DATABASE Heda Esmati Received Received
  106-OP LIVER TRANSPLANTATION (LT) IN HIGH-MELD (= 30) PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): SINGLE-CENTER EXPERIENCE WITH 90 CASES Andrea Della Penna Received Received
  107-OP EVOLUTION OF INDICATION IN LIVER TRANSPLANTATION IN ITALY: THE CNT REGISTRY STUDY; ECALITA STUDY. ON BEHALF OF ECALITA STUDY GROUP Tommaso Maria Manzia Received Received
  108-OP IMPACT EXTENDED LIVING DONOR CRITERIA FOCUSING ON DONOR SAFETY IN LIVING DONOR LIVER TRANSPLANTATION Joodong Kim Received Received
  109-OP HLA-DQ DISPARITIES AND KIDNEY TRANSPLANT OUTCOME Aleksandar Senev Received Received
  110-OP KIDNEY RECIPIENTS CHARACTERISTICS QUESTIONED THE DISCRIMINATIVE CAPACITIES OF KIDNEY DONOR RISK INDEX: AN EXTERNAL VALIDATION FROM A FRENCH COHORT Anne-Hélène Querard Received Received
  111-OP DONOR FACTORS -FOR KIDNEYS ACCEPTED FOR TRANSPLANTATION- MARGINALLY IMPACT TRANSPLANT OUTCOMES. CONCLUSIONS FROM NATIONWIDE PAIRED OUTCOME ANALYSES Jan Lindeman Received Received
  112-OP IMPACT OF ASIAN AND BLACK DONOR AND RECIPIENT ETHNICITY ON THE OUTCOMES AFTER DECEASED DONOR KIDNEY TRANSPLANTATION IN THE UNITED KINGDOM Abdul Rahman Hakeem Received Received
  113-OP PREDICTING NUCLEAR RENOGRAPHY BASED SPLIT RENAL FUNCTION IN LIVING DONOR TRANSPLANTATION WITH CT BASED MEASURED SPLIT RENAL VOLUMES Bahattin Ozkul Received Received
  114-OP EPITOPE DISTRIBUTION AND FEASIBILITY OF PIRCHE-II T-CELL MATCHING FOR RENAL TRANSPLANTATION IN CANADA Karen R Sherwood Received Received
  115-OP ITALIAN NATIONAL KIDNEY ALLOCATION ALGORHITM (INKAA): APPLICATION AND FIRST RESULTS Andrea Ricci Received Received
  116-OP THE IMPACT OF COLD ISCHAEMIA TIME ON OUTCOMES OF LIVING DONOR KIDNEY TRANSPLANTATION IN THE UK LIVING KIDNEY SHARING SCHEME Stijn Van De Laar Received Received
  117-OP CLOSING THE GAP: EXAMINING WAIT LIST OUTCOMES FOR THE MOST HIGHLY SENSITIZED CANDIDATES IN THE USA ACROSS REGIONS Miriam Manook Received Received
  118-OP THE REMUZZI SCORE IS A SAFE DECISION-MAKING TOOL AND UTILIZES MORE KIDNEYS FOR TRANSPLANT COMPARED TO DONOR EGFR Annemarie Weissenbacher Received Received
  119-OP LONG-TERM EVOLUTION OF KIDNEY GRAFT DONATION PROCEDURES IN UNCONTROLLED DONORS AFTER CARDIAC DEATH IN THE COMMUNITY OF MADRID Alonso Mateos-Rodriguez Received Received
  120-OP MODIFIED FRAILITY INDEX (MFI-11): A SIMPLE TOOL TO ACCESS FRAILTY IN OLDER KIDNEY TRANSPLANT WAITING LIST POPULATION Mariana Sousa Received Received
  121-OP COMPARING OUTCOMES IN RIGHT VERSUS LEFT KIDNEY TRANSPLANTATION; A SYSTEMATIC REVIEW AND META-ANALYSIS Caitlin Carolan Received Received
  122-OP ARE UNSPECIFIED KIDNEY DONORS TREATED DIFFERENTLY TO SPECIFIED KIDNEY DONORS? VIEWS OF UK TRANSPLANT PROFESSIONALS Mira Zuchowski Received Received
  123-OP UK DECEASED DONATION AND TRANSPLANT ACTIVITY IN PAEDIATRICS FOR 2019 – 2020 Chloe Brown Received Received
  124-OP THE END STAGE RENAL DISEASE (ESRD) IN ANORECTAL MALFORMATION (ARM) PATIENTS: RISK FACTORS AND OUTCOME. Miriam Duci Received Received
  125-OP PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS. Reshma Rana Magar Received Received
  129-OP THE OUTCOME OF PLASMA CELL-RICH ACUTE REJECTION IN KIDNEY TRANSPLANTATION, IS IT REALLY POOR? Tarek Mahmoud Received Received
  131-OP HYPERACUTE HUMORAL NON-HLA ALLOGRAFT REJECTION AND PROTEIN S DEFICIENCY DISEASE, CASE REPORT AND REVIEW. Luis Garcia Covarrubias Received Received
  132-OP ALLOIMMUNE CELLULAR AND HUMORAL MONITORING IN A KIDNEY TRANSPLANT RECIPIENT THAT PRESENTS AN ACUTE LEUKEMIA TREATED WITH BLINATUMOMAB Paula Anton Pampols Received Received
  138-OP ORGAN DONOR WITH RT-PCR POSITIVE FOR SARS-COV-2, IS IT ALWAYS NO? José Moya Sánchez Received Received
  139-OP ORGAN DONATION IN KSA: COVID-19 PANDEMIC Besher Al-Attar Received Received
  140-OP BILATERAL PNEUMONIA IN A KIDNEY TRANSPLANT RECIPIENT THE COVID-19 ERA- SOMETIMES IT´S A ZEBRA Bojana Šimunov Received Received
  141-OP IMPACT OF THE CHANGE IN ORGAN DONATION LAW IN ENGLAND ON DONATION RATES IN THE MULTICULTURAL AND ETHNICALLY DIVERSE CITY OF LONDON Lucy Dames Received Received
  142-OP OPT OUT LEGISLATION IN THE UK – PRELIMINARY DATA Sue Madden Received Received
  143-OP DISPARITIES IN THE USE OF DONATION AFTER CARDIAC DEATH LIVER ALLOGRAFTS FROM DONORS OVER 60 YEARS OF AGE IN THE UNITED STATES VS. THE UNITED KINGDOM. Emmanouil Giorgakis Received Received
  145-OP COMPUTERISED INTEGRATION OF ALTERNATIVE LIVING DONOR KIDNEY TRANSPLANTATION PROGRAMS: FIRST PROMISING RESULTS FOR DIFFICULT-TO-MATCH PATIENTS Marry De Klerk Received Received
  146-OP ALTRUISTIC KIDNEY DONATIONS: OPTIMIZING UTILITY AND BENEFICENCE Muhammad Yahya Jan Received Received
  149-OP BETA-CELL DEATH, RATHER THAN INSULIN RESISTANCE, DRIVES HYPERGLYCAEMIA IN ORGAN DONORS. Iestyn Shapey Received Received
  151-OP DIFFERENTIALLY METHYLATED CELL FREE DNA MONITORING IN PANCREAS TRANSPLANT RECIPIENTS WITH FUNCTIONING GRAFT Maria José Ramírez-Bajo Received Received
  153-OP UTILITY OF DONOR-DERIVED CELL-FREE DNA IN PANCREAS-KIDNEY TRANSPLANTATION Pedro Ventura-Aguiar Received Received
  154-OP EFFICACY AND SAFETY OF PANCREAS TRANSPLANT ALONE (PTA) IN SUBJECTS WITH TYPE 1 DIABETES (T1D): 15 YEAR ACTUAL FOLLOW-UP Walter Baronti Received Received
  161-OP THE EXPRESSION LEVELS OF CIRCULATING MIR-101 AND MIR-27 ASSOCIATE WITH HEART TRANSPLANT ACUTE REJECTION Olga Gichkun Received Received
  162-OP REAL WORLD DATA OF EVEROLIMUS WITH OR WITHOUT CALCINEURIN-INHIBITORS ON LONGTERM OUTCOME AFTER HEART TRANSPLANTATION Markus J. Barten Received Received
  170-OP MEDICATION ADHERENCE AND FEAR OF REJECTION AFTER CONVERSION FROM DUAL TO MONOTHERAPY: A RANDOMIZED CONTROLLED TRIAL Regina Van Zanten Received Received
  172-OP I-DTI: A SECOND OPINION PLATFORM BETWEEN HEALTHCARE PROFESSIONALS RELATED TO ORGAN DONATION AND TRANSPLANTATION Estephan Arredondo Received Received
  176-OP CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION Angela Carvalho-Gomes Received Received
  180-OP RECIPIENT SEX AND ESTRADIOL LEVELS AFFECT TRANSPLANT OUTCOMES IN AN AGE-SPECIFIC FASHION Jasper Iske Received Received
  181-OP CXCR3+ CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES COULD HELP IN COVID-19 RESOLUTION IN KIDNEY TRANSPLANT RECIPIENTS Patricia Suàrez Fernández Received Received
  182-OP INCREASING DIAGNOSTIC ACCURACY IN RENAL TRANSPLANT PATIENT WITH ACUTE COVID-19 AND GRAFT FAILURE BY T CELL ANALYSIS IN PERIPHERAL BLOOD AND BIOPSY Ulrik Stervbo Received Received
  183-OP DETECTION OF PRE-EXISTING SARS-COV-2-REACTIVE T CELLS IN UNEXPOSED RENAL TRANSPLANT PATIENTS Arturo Blázquez Navarro Received Received
  184-OP COVID-19 SEVERITY INFLUENCES ANTI-SARS-COV2 ANTIBODIES TITER IN KIDNEY TRANSPLANT RECIPIENTS Francisco Gonçalves Received Received
  185-OP OUTCOMES OF KIDNEY TRANSPLANTATION AT THE EPICENTRE OF THE COVID-19 PANDEMIC: THE EXPERIENCE OF THE OSPEDALE MAGGIORE POLICLINICO Evaldo Favi Received Received
  186-OP IMPACT OF SARS-COV-2 INFECTION IN WAITING LIST FOR LIVER TRANSPLANTATION Anna Sessa Received Received
  187-OP LIVER TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS RECOVERED FROM COVID-19 INFECTION Ahad Eshraghian Received Received
  188-OP SARS-COV-2 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: ONE YEAR LATER. WHAT HAVE WE LEARNT? Joana Tavares Received Received
  189-OP LIVER TRANSPLANT RECIPIENTS WITH SARS-COV-2 INFECTION: RESULTS FROM AN ITALIAN MULTICENTER COHORT Chiara Mazzarelli Received Received
  190-OP COVID-19 MANAGEMENT IN PATIENTS AFTER HEART TRANSPLANTATION Maria Simonenko Received Received
  191-OP COVID-19 IN DECEASED RENAL TRANSPLANT RECIPIENTS Mariana Sousa Received Received
  192-OP EPIDEMIOLOGY AND CLINICAL RELEVANCE OF ACUTE KIDNEY INJURY IN COVID-19 KIDNEY TRANSPLANT RECIPIENTS Gabriele Guglielmetti Received Received
  193-OP INFLUENZA VACCINATION IN SOLID ORGAN TRANSPLANT RECIPIENTS: A NATIONWIDE POPULATION-BASED COHORT STUDY Susanne Dam Nielsen Received Received
  194-OP KIDNEY TRANSPLANT PATIENTS ARE ABLE TO GENERATE AND MOUNT VARICELLA ZOSTER-REACTIVE T CELL AND HUMORAL IMMUNITY FOLLOWING VARICELLA ZOSTER VACCINATION Toralf Roch Received Received
  195-OP CORRELATION BETWEEN COLD ISCHEMIA TIME AND THROMBOCYTOPENIA AFTER LIVER TRANSPLANTATION Marco Maria Pascale Received Received
  196-OP DANGER SIGNALS IN ORGAN PRESERVATION SOLUTION AFTER COLD ISCHEMIA IN LIVER TRANSPLANTATION: ACTIVATION OF MACROPHAGES AND ENDOTHELIAL CELLS Alberto Baroja-Mazo Received Received
  197-OP ROLE OF ACETYLCHOLINE IN LIVER GRAFTS FROM BRAIN DEAD DONORS WITH HEALTHY AND MARGINAL LIVERS WITH SIMPLE STEATOSIS OR NON-ALCOHOLIC STEATOHEPATITIS Marc Micó Carnero Received Received
  198-OP PERSISTENT BILIARY HYPOXIA AND LACK OF REGENERATION ARE KEY MECHANISMS IN THE PATHOGENESIS OF NON-ANASTOMOTIC STRICTURES AFTER LIVER TRANSPLANTATION Iris De Jong Received Received
  199-OP ANG-3777 TREATMENT ATTENUATES ISCHEMIA-REPERFUSION-INDUCED RENAL INJURY IN RAT AND DOG MODELS Prakash Narayan Received Received
  200-OP INFLUENCE OF THE ANESTHETIC METHOD ON THE OUTCOME OF A RODENT MODEL OF INTESTINAL ISCHEMIA-REPERFUSION INJURY Mathias Clarysse Received Received
  201-OP CLINICALLY APPLICABLE INTRALUMINAL PRESERVATION OF HUMAN SMALL BOWEL DOES NOT REDUCE HISTOLOGICAL DAMAGE COMPARED TO STANDARD VASCULAR FLUSH Anne Marye De Jong Received Received
  202-OP CALCIUM CARBONATE NANOPARTICLES IN AN EX VIVO RAT INTESTINAL PERFUSION MODEL: PREVENTION OF ISCHEMIC INJURY IN COLON AND SMALL INTESTINE Michele Finotti Received Received
  203-OP L-ARGININE PREVENTS ISCHEMIC INJURY IN EXPLANTED RAT INTESTINAL REGIONS IN AN EX VIVO PERFUSION MODE Michele Finotti Received Received
  204-OP ATTENUATION OF INTESTINAL ISCHEMIA-REPERFUSION INJURY IN A RODENT MODEL BY INTRAVENOUS ADMINISTRATION OF POLYETHYLENE GLYCOL Mathias Clarysse Received Received
  205-OP IN VIVO PHOSPHORYLATION OF C-MET BY ANG-3777, A HEPATOCYTE GROWTH FACTOR MIMETIC Latha Paka Received Received
  206-OP OXYGENATED VERSUS NON-OXYGENATED FLUSH OUT AND STORAGE OF DCD PORCINE LIVERS Isabel Brüggenwirth Received Received
  207-OP THE IRRADIATION-INDUCED RENAL ISCHEMIC PRECONDITIONING IS BLUNTED BY THE ORAL ADMINISTRATION OF THE ANTI-ANGIOGENIC AGENT, SUNITINIB Badr Khbouz Received Received
  208-OP ILOPROST INFUSION ACCELERATES THE RECOVERY OF RENAL FUNCTION IN PATIENTS EXPERIENCING IRI-RELATED DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANT Antonella Troiano Received Received
  209-OP IDENTIFICATION OF PREDICTIVE MARKERS FOR THE GENERATION OF WELL-DIFFERENTIATED IPSC-DERIVED KIDNEY ORGANOIDS Zhaoyu Du Received Received
  211-OP PORTAL VENOUS REPOPULATION OF DECELLULARISED RAT LIVER SCAFFOLDS WITH SYNGENEIC BONE MARROW STEM CELLS Mekhola Hoff Received Received
  215-OP IMPACT OF DELAYED GRAFT FUNCTION ON BASELINE DONOR DERIVED CELL-FREE DNA (DD-CFDNA) IN KIDNEY TRANSPLANT RECIPIENTS Bhavna Chopra Received Received
  220-OP DIFFERENTIALLY EXPRESSED TISSUE MICRORNAS DISTINGUISH SPECIFIC DISEASE PHENOTYPES FOLLOWING KIDNEY TRANSPLANTATION Špela Borštnar Received Received
  228-OP MAINTENANCE OF A DECEASED-DONOR KIDNEY TRANSPLANTATION PROGRAM DURING PANDEMIC SARS-COV-2 Richard Dumbill Received Received
  230-OP IS IT SAFE TO RECEIVE KIDNEYS FROM DECEASED KIDNEY DONORS WHO TESTED POSITIVE FOR COVID-19 INFECTION? Hatem Ali Received Received
  231-OP A NATIONAL RESPONSE TO COVID PRIORITISING LIVER TRANSPLANT RECIPIENTS WITH THE HIGHEST NEED PROVIDED EXCELLENT OUTCOMES IN THE UK Steven Masson Received Received
  232-OP COVID-19 IN LIVER TRANSPLANT CANDIDATES: WAIT-LIST OUTCOMES AND POST-TRANSPLANT COURSE Giovanni Perricone Received Received
  233-OP PANCREAS TRANSPLANTATION IN THE TIME OF COVID. A SINGLE CENTRES EXPERIENCE Ann Etohan Ogbemudia Received Received
  234-OP A CASE SERIES OF PAEDIATRIC KIDNEY TRANSPLANTS DURING THE ONGOING COVID-19 PANDEMIC Sergio Assia-Zamora Received Received
  235-OP ANASTOMOSIS TIME IS AN INDEPENDENT RISK FACTOR FOR PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY Christelle M. Vandervelde Received Received
  236-OP FEASIBILITY OF SURVEILLANCE AFTER LUNG TRANSPLANTATION USING MULTIVOLUME MRI INSTEAD OF IONIZING RADIATION TECHNIQUES IN CYSTIC FIBROSIS PATIENTS Alessandro Palleschi Received Received
  237-OP CHRONIC KIDNEY DISEASE: A FREQUENT COMPLICATION IN PATIENTS WITH LUNG TRANSPLANT Marisa Serrano Salazar Received Received
  238-OP COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG Víctor Donoso Trenado Received Received
  239-OP CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN Raquel López-Vilella Received Received
  240-OP IS HEART TRANSPLANTATION A VALUABLE OPTION IN PATIENTS WITH SYSTEMIC RARE DISEASES? Concetta Di Nora Received Received
  241-OP SINGLE CENTER ASSESSMENT OF CARDIAC TRANSPLANTATION RESULTS COMPARING URGENT VERSUS ELECTIVE REGIMEN Mariafrancesca Fiorentino Received Received
  242-OP WAITLIST OUTCOMES AFTER THE IMPLEMENTATION OF A NEW ALLOCATION SYSTEM FOR URGENT HEART TRANSPLANTATION IN ITALY Alessandra Oliveti Received Received
  243-OP LIFE OF AN HEART FAILURE AND HEART TRANSPLANT CENTER IN THE COVID ERA : NEVER GIVE IN TO FEAR, USE TELEMEDICINE. Marco Masetti Received Received
  244-OP MYOCARDIAL SCAR BURDEN CORRELATES WITH CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION AND NT-PROBNP SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS Gregor Poglajen Received Received
  245-OP DECREASED CIRCULATING CD34+ CELL COUNT IS ASSOCIATED WITH CORONARY ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS Gregor Poglajen Received Received
  246-OP MONITORING LYMPHOCYTE SUBPOPULATIONS IN PERIPHERAL BLOOD IN HEART TRANSPLANT RECIPIENTS. A NEW TOOL TO DETECT CAV? Clara Simón Ramón Received Received
  247-OP RISK FACTORS AND OUTCOMES OF ACUTE KIDNEY INJURY AFTER HEART TRANSPLANT Nicolina Conti Received Received
  248-OP THE RISK OF SKIN CANCER DOES NOT CORRELATE WITH VITAMIN D SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS Gregor Poglajen Received Received
  249-OP MAGNETIC RESONANCE IMAGING TO ASSESS RENAL FLOW DISTRIBUTION DURING EX VIVO NORMOTHERMIC MACHINE PERFUSION Veerle A. Lantinga Received Received
  251-OP DONATION AFTER CIRCULATORY DEATH (DCD) STRATEGY IN ITALY: THE BARRIER OF A PROLONGED NO-TOUCH PERIOD CAN BE OVERCOME Lucia Masiero Received Received
  252-OP NORMOTHERMIC LIQUID VENTILATION ATTENUATES INFLAMMATION FROM ISCHEMIA-REPERFUSION INJURY IN AN EX VIVO RAT MODEL Helena M. Linge Received Received
  253-OP NORMOTHERMIC MACHINE PERFUSION FACILITATES DELIVERY OF RNA INTERFERENCE THERAPEUTICS IN DONOR KIDNEYS Emily Thompson Received Received
  254-OP TREATING CIRCULATORY DEATH DONOR KIDNEYS WITH ANTI-FIBROTIC DRUGS USING EX VIVO PRECISION CUT KIDNEY SLICES Leonie Van Leeuwen Received Received
  255-OP COMPLEMENT IS ACTIVATED DURING NORMOTHERMIC MACHINE PERFUSION OF PORCINE AND DISCARDED HUMAN KIDNEYS Leonie Venema Received Received
  256-OP NORMOTHERMIC REGIONAL PERFUSION VERSUS RAPID RECOVERY IN CONTROLLED DONATION AFTER CIRCULATORY DEATH KIDNEY TRANSPLANTATION Maria Padilla Received Received
  257-OP IMMUNE CELL PROFILING AND ASSESSMENT OF INFLAMMATORY CYTOKINE LEVELS IN THE PERFUSATE DURING NORMOTHERMIC MACHINE PERFUSION OF HUMAN LIVER ALLOGRAFTS Margot Fodor Received Received
  258-OP EXPLORING THE RELEASE OF EXTRACELLULAR VESICLES IN PERFUSATE AND BILE AS AN ADDITIONAL TOOL TO UNRAVEL MECHANISMS OF FUNCTION OF LIVER NMP. Nicholas Gilbo Received Received
  259-OP METABOLIC AND IMMUNOLOGICAL ALTERATIONS IN NORMOTHERMIC MACHINE PERFUSION OF THE LIVER AS COMPARED TO STATIC COLD STORAGE Maria Letizia Lo Faro Received Received
  261-OP MICROVASCULAR OBSTRUCTIONS IN PORTAL BILE DUCT CAPILLARIES AND HEPATIC SINUSOIDS DURING NORMOTHERMIC MACHINE PERFUSION OF MARGINAL HUMAN LIVERS Samuel Tingle Received Received
  262-OP RE-WRITING THE DEFINITION OF HIGH-RISK AND FUTILE DCD LIVER TRANSPLANTATION WITH NRP Ahmed E Sherif Received Received
  263-OP BENCH SURGERY AND KIDNEY AUTO-TRANSPLANTATION IN RESCUE OF GERM-CELL RESIDUAL MASS. 3D MODELS UTILITY IN SURGICAL PLANNING Victoria Gomez Received Received
  265-OP AN ALTERNATIVE WAY OF LAPAROSCOPIC PERITONEAL FENESTRATION BY USING A SECOND LAPAROSCOPE AND TRANSILLUMINATION TO MANAGE POST-TRANSPLANT LYMPHOCELES Vasileios Tatsis Received Received
  271-OP INEQUITABLE ACCESS TO TRANSPLANTS: PERSONS WITH IMPAIRED DECISION-MAKING CAPACITY Rebecca Thom Received Received
  272-OP FRIEND OR FOE: LAW, REGULATION AND THE PSYCHOSOCIAL ASSESSMENT OF LIVING KIDNEY DONORS Bonnie Venter Received Received
  273-OP FAMILY´S LEGAL ROLE IN DECEASED ORGAN PROCUREMENT. AN EUROPEAN AND COMPARATIVE LAW STUDY Marina Morla Received Received
  274-OP WITHDRAWING LIFE SUSTAINING TREATMENT AND ORGAN DONATION OF BRAIN DEATH PATIENTS Seungrye Jeong Received Received
  276-OP H2S ENRICHED FLUSH-OUT IN DBD AND NON-DBD PORCINE KIDNEYS Hanno Maassen Received Received
  277-OP PATTERNS AND INHIBITION OF CELL DEATH DURING STATIC COLD STORAGE OF HUMAN KIDNEYS Jenna DiRito Received Received
  278-OP COMBINED DRUGS APPROACH TO PREVENT ISCHEMIA-REPERFUSION INJURY DURING TRANSPLANTATION OF LIVERS (CAPITL): RESULTS OF A RANDOMIZED CONTROLLED TRIAL Nicolas Meurisse Received Received
  280-OP MODIFIED IMMUNE CELL (MIC) INFUSION IN KIDNEY TRANSPLANTATION Christian Morath Received Received
  281-OP CHARACTERISATION OF DISTINCT GRAFT INFILTRATES FOLLOWING REGULATORY T CELL THERAPY IN KIDNEY TRANSPLANT RECIPIENTS Matthew Brook Received Received
  282-OP LONG TERM FOLLOW-UP OF LIVER TRANSPLANT RECIPIENTS AFTER ALLOGENEIC MESENCHYMAL STROMAL CELL INFUSION Morgan Vandermeulen Received Received
  283-OP INCIDENCE AND PREDICTORS OF FAILED KIDNEY ALLOGRAFT INTOLERANCE SYNDROME Carolina Ormonde Received Received
  284-OP LONG-TERM APHERESIS IN THE MANAGEMENT OF PATIENTS WITH RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION: A CASE SERIES Audrey Uffing Received Received
  285-OP TRANSPLANTECTOMY VERSUS NON-TRANSPLANTECTOMY AFTER FAILED KIDNEY TRANSPLANT. A SYSTEMATIC REVIEW AND META-ANALYSIS. Paschalis Gavriilidis Received Received
  286-OP ASSOCIATION BETWEEN DECEASED DONOR ACUTE KIDNEY INJURY ASSESSED BY BASELINE SERUM CREATININE BACK-ESTIMATION AND GRAFT SURVIVAL Rémi Lenain Received Received
  287-OP CLINICAL AND IMMUNOLOGICAL FOLLOW-UP OF VERY LONG-TERM KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CALCINEURIN INHIBITORS Amaury Dujardin Received Received
  288-OP DEEP-LEARNING BASED PREDICTION OF CLINICAL ENDPOINTS IN RENAL PRE-IMPLANTATION BIOPSIES USING SLIDE-LEVEL LABELS Ka Ho Tam Received Received
  289-OP MOLECULAR AND CELLULAR MECHANISMS OF LIPOCALIN-2 MEDIATED RENOPROTECTION IN KIDNEY TRANSPLANTATION Anna Pfefferkorn Received Received
  290-OP REVISITING THE CHANGES IN THE BANFF CLASSIFICATION FOR ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION Jasper Callemeyn Received Received
  291-OP INTERSTITIAL FIBROSIS IN PREIMPLANTATION KIDNEY BIOPSIES OF EXTENDED CRITERIA DONORS PREDICTS LONG-TERM GRAFT SURVIVAL. Elisabetta Bussalino Received Received
  292-OP THREE-MONTH GRAFT FUNCTION OF KIDNEYS RETRIEVED 4.5 HOURS AFTER CIRCULATORY DEATH Deepti Antony Received Received
  293-OP ENDOTHELIAL TO MYOFIBROBLAST TRANSITION (ENMT) AND CAPILLARY VEGF LOSS ENHANCES THE DEVELOPMENT OF INTERSTITIAL FIBROSIS AND GLOMERULOSCLEROSIS Binnaz Handan Ozdemir Received Received
  294-OP AGGRAVATION OF FIBRIN DEPOSITION AND MICROTHROMBUS FORMATION WITHIN THE GRAFT DURING KIDNEY TRANSPLANTATION Tamar Van Den Berg Received Received
  295-OP HYPERLEPTINAEMIA AND LOW VALUES OF INTERLEUKIN 10 AS RISK FACTORS FOR GRAFT REJECTION IN PROTOCOL BIOPSY AFTER KIDNEY TRANSPLANTATION Ivana Dedinská Received Received
  296-OP POST-TRANSPLANTATION EARLY BLOOD TRANSFUSION AND KIDNEY ALLOGRAFT OUTCOMES: A SINGLE-CENTER OBSERVATIONAL STUDY Mehdi Maanaoui Received Received
  299-OP CORE SIGNATURE OF REJECTION-SPECIFIC CYTOKINES AND CHEMOKINES IN HEART BIOPSIES AFTER TRANSPLANTATION Lena Radomsky Received Received
  301-OP CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE SCREENING OF CARDIAC ALLOGRAFT VASCULOPATHY, TWO YEARS OF EXPERIENCE Stefan Roest Received Received
  309-OP MALIGNANCIES BEFORE AND AFTER HEART TRANSPLANTATION – A SINGLE-CENTRE LONG-TERM OUTCOME STUDY Caroline Stenman Received Received
  310-OP CANCER TRANSMISSIONS AND NON-TRANSMISSIONS FROM SOLID ORGAN TRANSPLANTATION: AN AUSTRALIAN COHORT STUDY James Hedley Received Received
  311-OP SURVIVAL WITH TABELECLEUCEL IN PATIENTS WITH EPSTEIN-BARR VIRUS-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER SOLID ORGAN TRANSPLANT S Prockop Received Received
  312-OP DONOR-TRANSMITTED CANCERS: THE SPANISH EXPERIENCE Beatriz Dominguez-Gil Received Received
  313-OP SERIOUS ADVERSE EVENTS (SAE) AND SERIOUS ADVERSE REACTIONS (SAR) REPORTING IN GERMANY FROM 2016-2020: ANALYSIS OF DONOR-TRANSMITTED MALIGNANCY. Klaus Böhler Received Received
  314-OP HETEROGENEOUS INFLUENCE OF DIFFERENT FORMS OF POST-TRANSPLANT DE NOVO CANCER ON SURVIVAL OF KIDNEY GRAFTS – A COLLABORATIVE TRANSPLANT STUDY REPORT Christian Unterrainer Received Received
  315-OP POST-TRANSPLANT MALIGNANCIES AFTER PANCREAS TRANSPLANTATION: INCIDENCE AND IMPLICATIONS ON LONG-TERM OUTCOME FROM A SINGLE-CENTER PERSPECTIVE Felix Julius Krendl Received Received
  316-OP T AND B CELL ABUNDANCE ARE STRONGLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES Simon Schran Received Received
  317-OP IMPACT OF CANCER ON THE RISK OF DEATH AMONG ITALIAN KIDNEY TRANSPLANT RECIPIENTS WITH A FUNCTIONING GRAFT: ITALIAN TRANSPLANT & CANCER COHORT STUDY Pierluca Piselli Received Received
  318-OP MANAGEMENT OF THE KIDNEY TRANSPLANT PATIENT WITH CANCER": REPORT FROM A CONSENSUS CONFERENCE. Gionata Spagnoletti Received Received
  319-OP RETROSPECTIVE STUDY OF NEOPLASM TRANSMISSION FROM ORGAN DONOR TO RECIPIENT Helena Martí Grífol Received Received
  320-OP POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE CENTER STUDY Stathis Tsiakas Received Received
  321-OP DISTINCT IMPACT OF POSTTRANSPLANT MALIGNANCIES AND MORTALITY IN DIFFERENT IMMUNOSUPPRESSIVE THERAPY PROTOCOLS BASED- PERIODS IN A LONG-TERM FOLLOW-UP Ignacio Revuelta Received Received
  322-OP PREVALENCE AND CLINICAL SIGNIFICANCE OF PANCREATIC CYSTIC LESIONS IN IMMUNOSUPPRESSED PATIENTS WITH SOLID ORGAN TRANSPLANTATION Young-Dong Yu Received Received
  325-OP PHASE 3 OPEN-LABEL STUDY OF MARIBAVIR FOR REFRACTORY/RESISTANT CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS: SUBGROUP ANALYSES BY ORGAN TYPE Nassim Kamar Received Received
  326-OP SURVEILLANCE AND TREATMENT OF HUMAN HERPESVIRUS 8 IN TRANSPLANT RECIPIENTS: A STRICT PROTOCOL TO BRING MORTALITY TOWARD ZERO alessandra mularoni Received Received
  327-OP MTOR INHIBITORS PREVENT CMV INFECTION THROUGH THE RESTORATION OF FUNCTIONAL ?? AND G? T CELLS IN KIDNEY TRANSPLANTATION hannah kaminski Received Received
  328-OP PRECISION MEDICINE IN TRANSPLANTATION: MAGNITUDE, DURATION, AND IMPACT OF CMV VIREMIA ON GRAFT AND MORTALITY OUTCOMES Paul A Keown Received Received
  330-OP BARIATRIC SURGERY COMPROMISES MACROPHAGE DRIVEN ALLOIMMUNITY IN OBESE TRANSPLANT RECIPIENTS Jasper Iske Received Received
  331-OP MAXIMIZE THE USE OF ARTIFICIAL INTELLIGENCE IN ORGAN DONATION AND TRANSPLANTATION MANAGEMENT TO IMPROVE EFFICACY AND SAFETY Wenshi Jiang Received Received
  332-OP OUTPATIENT URETERIC STENT REMOVAL FROM KIDNEY TRANSPLANT RECIPIENTS USING ISIRIS IS FEASIBLE, SAFE AND COST-EFFECTIVE Fanourios Georgiades Received Received
  333-OP MULTILINEAR EGFR PROGRESSION PATTERN IS ASSOCIATED WITH GRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS Ruth Rahamimov Received Received
  334-OP PERSPECTIVES OF AUTOLOGOUS BLOOD TRANSFUSION AS A TOOL FOR PREVENTING IMMUNIZATION DURING NATIVE KIDNEY NEPHRECTOMY IN WAITING LIST CANDIDATES Alicja Debska-Slizien Received Received
  335-OP QUALITY OF LIFE AFTER LIVER TRANSPLANTATION, A CROSS-SECTIONAL SINGLE CENTRE STUDY. Mathias Vidgren Received Received
  336-OP QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY Midas Mulder Received Received
  337-OP COMPARING RENAL FUNCTION IN LT RECIPIENTS WITH LOW-DOSE TACROLIMUS AND SIROLIMUS VERSUS NORMAL-DOSE TACROLIMUS, A MULTICENTER RCT; 24-MONTH RESULTS Midas Mulder Received Received
  338-OP CLIF-C ACLF SCORE DOES NOT PREDICT SURVIVAL AFTER LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE Joris Blondeel Received Received
  339-OP LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE: A SINGLE CENTRE EXPERIENCE Joris Blondeel Received Received
  340-OP VARIOUS SELECTION CRITERIA FOR PRETRANSPLANT MYOSTEATOSIS AND THEIR VALUE IN THE ASSESSMENT OF SHORT- AND LONG-TERM OUTCOMES FOLLOWING OLT Zoltan Czigany Received Received
  341-OP ULTRA-LONG-TERM OUTCOME AND ITS DETERMINANTS AFTER LIVER TRANSPLANTATION IN ADULTS Laura Boer Received Received
  342-OP THERAPEUTIC ANTICOAGULATION IN PREVENTION OF RECURRENT PORTAL VEIN THROMBOSIS AFTER LIVER TRANSPLANTATION: UTILITY OR FUTILITY? Michel Rayar Received Received
  343-OP A PHOTOGRAPH OF PATIENTS APPROACHING LIVER TRANSPLANTATION: ASSESSMENT OF THE PSYCHOLOGICAL OUTCOME PREDICTORS Marco Valente Received Received
  344-OP AN ECONOMIC EVALUATION OF THE COST OF COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION IN THE UK NATIONAL HEALTH SYSTEM Dimitri A. Raptis Received Received
  346-OP VIEWS AND EXPERIENCES OF PATIENTS AWAITING A TRANSPLANT AND OF TRANSPLANTED PATIENTS: A NATIONAL SURVEY TO UNDERSTAND THEIR NEEDS Lia Bellis Received Received
  348-OP PSYCHOLOGICAL EVALUATION OF DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS DURING COVID-19 Sanem Cimen Received Received
  352-OP BILIARY RECONSTRUCTION USING HIGH BILIARY RADICAL IS SAFE OPTION FOR MULTIPLE GRAFT BILE DUCT IN RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION JOODONG KIM Received Received
  353-OP RE-THINKING OF T-TUBE USE AT WHOLE LIVER TRANSPLANTATION: AN ANALYSIS ON THE RISK OF DELAYED GRAFT FUNCTION Riccardo Pravisani Received Received
  354-OP POST-LIVER TRANSPLANT INFERIOR VENA CAVA STENOSIS IN A LARGE VOLUME UK CENTRE. Fanourios Georgiades Received Received
  356-OP PHYSIOLOGICAL RECONSTRUCTIONS IN LIVER TRANSPLANTATION WITH NON-TUMORAL EXTENDED PORTAL VEIN THROMBOSIS: RESULTS AT TWO LARGE VOLUME CENTRES Domenico Pinelli Received Received
  357-OP EFFECT OF PRE-TRANSPLANT SARCOPENIA ON THE ESTIMATION OF STANDARD LIVER VOLUME IN LIVING-DONOR LIVER TRANSPLANT CANDIDATES Riccardo Pravisani Received Received
  358-OP A PROSPECTIVE ANALYSIS OF CLINICAL FRAILTY ASSESSMENT AND TELOMERE LENGTH IN A NATIONAL COHORT OF LIVER TRANSPLANT CANDIDATES Sinead Cremen Received Received
  359-OP FAST-TRACK LIVER TRANSPLANTATION: 100 MONTHS OF A FULL-FLEDGED ERAS PROTOCOL Gonzalo Rodríguez-Laiz Received Received
  360-OP ARE WE READY FOR BARIATRIC SURGERY IN A LIVER TRANSPLANT PROGRAM? A META-ANALYSIS Victor López-López Received Received
  369-OP OUTCOMES OF RABBIT ANTI-THYMOCYTE GLOBULIN VERSUS IL-2 RA INDUCTION THERAPIES IN 2DR MISMATCH RENAL TRANSPLANT RECIPIENTS Hatem Ali Received Received
  373-OP GRAFT UTILIZATION AFTER NORMOTHERMIC REGIONAL PERFUSION IN CONTROLLED DONATION AFTER CIRCULATORY DEATH - 5-YEAR EXPERIENCE FROM FRANCE Xavier Muller Received Received
  374-OP HYPOTHERMIC OXYGENATED MACHINE PERFUSION (HOPE) IN LIVER TRANSPLANTATION FOR EXPANDED CRITERIA DONOR GRAFT: SINGLE CENTER EXPERIENCE Luca Perin Received Received
  380-OP OPERATIONAL TOLERANCE-RELATED GENES ALLOW NON-INVASIVE DETECTION OF SUBCLINICAL REJECTION AT ONE YEAR AFTER RENAL TRANSPLANTATION Richard Danger Received Received
  382-OP AGE-RELATED PROTEOMIC DIFFERENCES IN DECEASED DONOR KIDNEYS ASSOCIATE WITH 12-MONTH POSTTRANSPLANTATION OUTCOME Philip Charles Received Received
  384-OP SUBOPTIMAL RECIPIENT OUTCOMES CORRELATE TO INCREASED INFLAMMATORY MARKERS IN DECEASED AFTER BRAIN DEATH DONORS Rebecca Vaughan Received Received
  387-OP THE EFFECT OF DONOR DIABETES-ASSOCIATED GENOTYPES ON OUTCOMES AFTER PANCREAS TRANSPLANTATION. Charles Sneddon Received Received
  388-OP PANCREAS TRANSPLANTATION FROM DONORS DECLARED DEATH BY CIRCULATORY CRITERIA: INITIAL EXPERIENCE IN SPAIN. Joana Ferrer Received Received
  389-OP METABOLIC OUTCOMES OF PANCREAS TRANSPLANT ALONE FROM DONATION AFTER CIRCULATORY DEATH DONORS - THE UK REGISTRY ANALYSIS Jeevan Gopal Received Received
  390-OP HUMAN AMNIOTIC EPITHELIAL CELLS PROTECT PANCREATIC ISLETS AGAINST PRO-INFLAMMATORY CYTOKINES Fanny Lebreton Received Received
  391-OP OUTCOMES OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS FROM DONATION AFTER CIRCULATORY DEATH DONORS IN THE UK: A NATIONAL REGISTRY ANALYSIS Nikolaos Karydis Received Received
  392-OP DEVELOPMENT OF EX VIVO NORMOTHERMIC PERFUSION AS AN INNOVATIVE METHOD TO ASSESS PANCREASES AFTER PRESERVATION Ann Etohan Ogbemudia Received Received
  393-OP THE EUROPEAN P-PASS AND US PDRI SCORES ARE ASSOCIATED WITH INCREASED RISK OF PANCREAS GRAFT REJECTION Ky-Leigh Ang Received Received
  394-OP IMPROVED PANCREATIC GRAFTS SURVIVAL WITH OPERATING PROTOCOL AMENDMENTS. Pawel Skrzypek Received Received
  395-OP POST-TRANSPLANT INFLAMMATION IS LOCALISED TO THE PANCREAS GRAFT AND ASSOCIATED WITH EARLY GRAFT THROMBOSIS Kristina Rydenfelt Received Received
  396-OP COMPARISON OF DRB1 AND DQB1 ALLELE FREQUENCIES AND PRE-TRANSPLANT ANTI-HLA ANTIBODIES IN PATIENTS WAITING FOR PANCREAS VS. KIDNEY TRANSPLANT Eric Kauffman Received Received
  397-OP TEN YEARS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATIONS - SINGLE CENTRE NATIONWIDE EXPERIENCE Kaisa Ahopelto Received Received
  398-OP PANCREAS GRAFT SALVAGE AFTER DUODENAL LEAK - FOLEY OR FOLLY? OUTCOMES FROM OVER 1000 PANCREAS TRANSPLANTS Fungai Dengu Received Received
  399-OP FIRST POSTOPERATIVE DAY PLASMA AMYLASE CAN BE USED TO DETECT PATIENTS AT RISK OF COMPLICATIONS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION Akseli Bonsdorff Received Received
  400-OP ISLETS LOADED IN HYDROGEL DERIVED FROM HUMAN AMNIOTIC MEMBRANE REVERSE DIABETES IN IMMUNODEFICIENT MICE Kevin Bellofatto Received Received
  401-OP BLOCKADE OF THE IL-21 PATHWAY: A NEW PERSPECTIVE FOR THE TREATMENT OF T AND B CELL MEDIATED ALLOGENEIC RESPONSES AFTER TRANSPLANTATION Carla Baan Received Received
  402-OP PROLIFERATION OF CO-STIMULATION BLOCKADE RESISTANT-T CELLS REQUIRED EARLY IFN? PATHWAY ACTIVATION Florence Herr Received Received
  403-OP DETERMINING THE T CELLRECEPTOR REPERTOIRE IN DIRECT PEPTIDE-MHC ALLORECOGNITION BY CD8+ T CELLS Alexandra Sharland Received Received
  404-OP INCREASED FREQUENCY OF T CELL-MEDIATED REJECTION ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN HLA-DSA NEGATIVE TRANSPLANT RECIPIENTS David Rodriguez Fuentes. Received Received
  405-OP DO NOT BLAME THE INNOCENT: G?T CELLS ARE NOT INVOLVED IN DONOR SPECIFIC ANTIBODY GENERATION AFTER SOLID ORGAN TRANSPLANTATION Xavier Charmetant Received Received
  406-OP IMMUNOLOGICAL BEHAVIOR OF EARLY GRAFT INFILTRATING CELLS UNTIL 3 DAYS AFTER MURINE SKIN TRANSPLANTATION Ryo Kanazawa Received Received
  407-OP GENOME-WIDE MISMATCH AND DELETION ANALYSIS IN KIDNEY TRANSPLANTATION Salla Markkinen Received Received
  408-OP DONOR-RECIPIENT GENETIC MISMATCH IS ASSOCIATED WITH LIVER ALLOGRAFT REJECTION Lianne Nieuwenhuis Received Received
  409-OP SOLVENT ACCESSIBLE AMINO ACID MISMATCHES CALCULATED BY HLA-EMMA AS INDEPENDENT RISK FACTOR FOR DEATH-CENSORED GRAFT FAILURE IN RENAL TRANSPLANTATION Suzanne Bezstarosti Received Received
  410-OP LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION Florian Kälble Received Received
  411-OP ANTI-THYMOCYTE GLOBULIN MEDIATED B-CELL ACTIVATION Moritz Muckenhuber Received Received
  412-OP MESENCHYMAL STROMAL CELL DERIVED MEMBRANE PARTICLES ARE INTERNALIZED BY MACROPHAGES AND ENDOTHELIAL CELLS AND EXHIBIT IMMUNOMODULATORY EFFECTS Martin Hoogduijn Received Received
  413-OP DELINEATING THE IMMUNOGENICITY OF GRAFT COMPONENTS IN COMPOSITE TISSUE ALLOTRANSPLANTATION Barbara Kern Received Received
  414-OP LOCAL IMMUNOSUPPRESSION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: PAVING THE WAY FOR A SAFER ALTERNATIVE Isabel Arenas Hoyos Received Received
  415-OP MANAGEMENT OF CONGENITAL PORTOSYSTEMIC SHUNTS Lilia Martinez de la maza Received Received
  416-OP HEPATOPORTOENTEROSTOMY VERSUS PRIMARY LIVER TRANSPLANTATION FOR BILIARY ATRESIA Dor Yoeli Received Received
  417-OP THE ROLE OF VASCULAR ADHESION PROTEIN-1 IN THE PATHOGENESIS OF CHRONIC ALLOGRAFT HEPATITIS AFTER PAEDIATRIC LIVER TRANSPLANTATION Steffen Hartleif Received Received
  418-OP VEIN OUTFLOW OBSTRUCTION AFTER LEFT LATERAL SEGMENTS TRANSPLANT: EXPERIENCE AT A LARGE PEDIATRIC TRANSPLANTATION CENTER. Domenico Pinelli Received Received
  419-OP LIVER TRANSPLANTATION FOR LANGERHANS CELL HISTIOCYTOSIS : A PROTOCOL BASED APPROACH Jagadeesh Menon Received Received
  421-OP KIDNEY TRANSPLANTATION IN THE TRANSGENDER PATIENT- A CHALLENGE FOR CARE Irena Milaniak Received Received
  422-OP FIRST PERSON CONSENT: CHALLENGES TO APPROACHING FOR DONATION. Bethany Hall Received Received
  424-OP COLLABORATIVE WORKING- KEY TO MAINTAINING NORMAL ORGAN DONATION AND TRANSPLANT SERVICE DURING COVID PANDEMIC IN NORTHERN IRELAND Mary Hayes Received Received
  431-OP SYSTEMATIC SCREENING FOR SARS-COV-2 S1/S2 ANTIBODIES HELPS TO BETTER ASSESS THE REAL INCIDENCE OF COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS Louis Firket Received Received
  432-OP COMPARISON OF THE IMMUNE RESPONSES OF RENAL TRANSPLANT RECIPIENTS AFTER COVID-19 VERSUS SARS-COV2 VACCINATION Xavier Charmetant Received Received
  434-OP INCREASE ORGANS PROCURED AND TRANSPLANTED VIA A COMPREHENSIVE, INTEROPERABLE, AND SECURE DIGITAL DONOR AND TRANSPLANT MANAGEMENT PLATFORM John Piano Received Received
  435-OP IMPACT ON DONOR DETECTION AFTER THE IMPLEMENTATION OF QUALITY INDICATORS AND TPM TRAINING PROGRAM IN THE KINGDOM OF SAUDI ARABIA Estephan Arredondo Received Received
  436-OP THE DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION FROM 1998 TO 2019: RESULTS Carlo De Cillia Received Received
  437-OP ORGAN DONATION AND TRANSPLANT IN THE ENGLISH-SPEAKING CARIBBEAN REGION: 10 YEARS OF INTERNATIONAL COOPERATION Maria Gomez Received Received
  438-OP QUALITY MANAGEMENT SYSTEM APPLIED TO ORGAN DONATION: UNITED ARAB EMIRATES EXPERIENCE Maria Gomez Received Received
  439-OP SOLUBLE UROKINASE RECEPTOR AND MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS Christian Morath Received Received
  440-OP COMPARATIVE TRANSCRIPTOME ANALYSIS REVEALS A POTENTIAL ROLE OF C1QB IN CHRONIC ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFS. Mattia Rossi Received Received
  441-OP VALIDATION OF FLAVIN MONONUCLEOTIDE TO MONITOR QUALITY OF DONOR KIDNEYS DURING HYPOTHERMIC (OXYGENATED) MACHINE PERFUSION IN KIDNEY TRANSPLANTATION Fenna Van De Leemkolk Received Received
  442-OP MONITORING OF MOLECULAR PROFILING OF REGULATORY T CELL BIOMARKERS BY USING NON-INVASIVE STRATEGIES TO PREDICT OUTCOME IN RENAL TRANSPLANTATION. Angelica Canossi Received Received
  443-OP URINARY EXTRACELLULAR VESICLES AND VESICULAR CELL-FREE DNA AS POTENTIAL BIOMARKERS FOR KIDNEY ALLOGRAFT INJURY Ivana Sedej Received Received
  444-OP NUCLEAR FACTOR OF ACTIVATED T CELLS AS POTENTIAL PHARMACODYNAMIC BIOMARKER FOR THE RISK OF ACUTE AND SUBCLINICAL REJECTION IN LIVER RECIPIENTS Olga Millan Received Received
  445-OP CONNECTION OF BANK1, TOLERANCE, REGULATORY B CELLS, AND APOPTOSIS: PERSPECTIVES OF A REDUCTIONIST INVESTIGATION. Ludmilla Le Berre Received Received
  446-OP IMPACT OF STEATOSIS AND COLD ISCHEMIA TIME ON MITOCHONDRIAL RESPIRATION IN HUMAN LIVER ALLOGRAFTS Andras T. Meszaros Received Received
  447-OP APPLICATION OF THIN-FILM SOLID-PHASE MICROEXTRACTION TO BILE ANALYSIS - BILE FINGERPRINT AS A PROGNOSTIC MARKER DURING LIVER TRANSPLANTATION Kamil Luczykowski Received Received
  448-OP VIABILITY ASSESSMENT USING THE "SIX GENE SIGNATURE" DURING LIVER PERFUSION Rodrigo Figuerido Received Received
  449-OP ADVANTAGES OF PLASMATIC CXCL10 AS A PROGNOSTIC & DIAGNOSTIC BIOMARKER FOR THE RISK OF REJECTION AND SUBCLINICAL REJECTION IN KIDNEY TRANSPLANTATION. Olga Millan Received Received
  450-OP MONITORING KIDNEY GRAFT INJURY BY MEASURING DONOR-DERIVED CELL FREE DNA (DD-CFDNA) Emilio Rodrigo Received Received
  451-OP HUMAN CD81 EXTRACELLULAR VESICLES ARE RELEASED DURING NORMOTHERMIC MACHINE PERFUSION Wouter Woud Received Received
  452-OP TRANSFORMING GROWTH FACTOR-?1 EXPRESSION IN RENAL TRANSPLANT URETER TISSUE AND POST-TRANSPLANT URETERAL STRICTURE Emmy Hartog Received Received
  454-OP TREAT-TO-TARGET TRIAL OF CONTINUOUS SUBCUTANEOUS INSULIN-PUMP THERAPY IN NEW-ONSET DIABETES AFTER TRANSPLANTATION (SAPT-NODAT) Amelie Kurnikowski Received Received
  455-OP SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITORS IN RENAL TRANSPLANT DIABETIC PATIENTS. SINGLE CENTER PILOT STUDY. Claudia Muñoz Martínez Received Received
  461-OP PROPHYLACTIC DESENSITIZATION IN LUNG TRANSPLANT CANDIDATES WITH PRE-FORMED DONOR-SPECIFIC ANTIBODIES: 3-YEAR POST-TRANSPLANTATION OUTCOME. Olivier Brugière Received Received
  462-OP LUNG TRANSPLANT RECIPIENTS DEVELOPING EARLY DSA WITHIN THE FIRST MONTH EXHIBIT A HIGHER FREQUENCY OF NAÏVE AND A LOWER FREQUENCY OF MEMORY B CELLS Stella Christoph Received Received
  463-OP ALTERATION OF T LYMPHOCYTE SUBPOPULATIONS IN LUNG TRANSPLANTED PATIENT RECEIVING PROPHYLACTIC EXTRACORPOREAL PHOTOPHERESIS Ara Cho Received Received
  464-OP PARTICLE FLOW RATE FROM THE AIRWAYS AS A MARKER FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) Embla Bodén Received Received
  466-OP KAPOSI´S SARCOMA (KS) IN PEDIATRIC LIVER TRANSPLANTATION (LT) – 3 CLINICAL CASES Catarina Cordeiro Received Received
  469-OP LONG TERM SURVIVAL AFTER CHORIOCARCINOMA TRANSMITTED BY LIVER GRAFT: A SUCCESSFUL REPORT IN PAEDIATRIC TRANSPLANTATION Inês Pessanha Received Received
  477-OP CIRCULATING AND INTRAGRAFT DONOR(HLA)-SPECIFIC B CELLS DRIVE ANTIBODY-MEDIATED REJECTION IN HEART AND KIDNEY TRANSPLANT PATIENTS Alba Torija Received Received
  478-OP ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFT IS ASSOCIATED WITH AN INCREASE IN DIFFERENTIATED CD28-CD8+ T CELLS IN THE PERIPHERAL BLOOD Hoa Mai Received Received
  479-OP CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES PROTECT AGAINST CMV INFECTION IN KIDNEY TRANSPLANT RECIPIENTS Patricia Suàrez Fernández Received Received
  480-OP ANTIVIRAL TREATMENT PATTERNS FOR CYTOMEGALOVIRUS PREVENTION AMONG ADULT KIDNEY TRANSPLANT RECIPIENTS: A USRDS-MEDICARE LINKED DATABASE STUDY Carlos Santos Received Received
  481-OP DONOR CYTOMEGALOVIRUS SEROPOSITIVITY CLUSTERS WITH RISK FACTORS FOR DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTATION, BUT DOES NOT DIRECTLY CONTRIBUTE Richard Dumbill Received Received
  482-OP PREVENTION OF CYTOMEGALOVIRUS INFECTION BY EVEROLIMUS IN SEROPOSITIVE KIDNEY TRANSPLANT RECIPIENTS Lionel Couzi Received Received
  483-OP VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY FOR PREVENTION OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS: A RANDOMIZED CONTROLLED TRIAL Tomas Reischig Received Received
  484-OP INFECTION PATTERN IN EVEROLIMUS VERSUS MYCOPHENOLATE-BASED REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH RESULTS FROM THE TRANSFORM STUDY Franco Citterio Received Received
  485-OP OUTCOME OF EBV NEGATIVE RECIPIENTS OF EBV POSITIVE DONOR ORGAN TRANSPLANT IN A SINGLE CENTRE Caroline Dudreuilh Received Received
  486-OP TACROLIMUS METABOLISM RATE AND BK INFECTION IN RENAL TRANSPLANT PATIENTS Dalvir Kular Received Received
  487-OP RELATIONSHIP BETWEEN CARBAPENEM-RESISTANT ENTEROBACTERALES CARRIAGE AND GUT MICROBIOME AFTER LIVER TRANSPLANTATION: A PROSPECTIVE COHORT STUDY Matteo Rinaldi Received Received
  488-OP ASSOCIATION BETWEEN ACUTE GRAFT PYELONEPHRITIS AND KIDNEY GRAFT LOSS: A SINGLE-CENTER OBSERVATIONAL STUDY Mehdi Maanaoui Received Received
  489-OP BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS: RESULT FROM A DANISH COHORT WITH NATIONWIDE FOLLOW-UP Dina Leth Møller Received Received
  490-OP ENTEROCOCCAL INFECTIONS IN THE FIRST YEAR AFTER LIVER TRANSPLANTATION Daniel Bräuner Rasmussen Received Received
  491-OP SUPERFICIAL SURGICAL SITE INFECTION AT HAND-PORT SITE AFTER HAND ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY FOR LIVING DONOR KIDNEY TRANSPLANTATION Takahisa Hiramitsu Received Received
  492-OP CONTROLLED DONATION AFTER CIRCULATORY DEATH: IS THERE A RISK FACTOR OF CULTURE-POSITIVE PRESERVATION FLUID ON SOLID ORGANS FOR TRANSPLANTATION? María Figueras Received Received
  493-OP THE "CRITICAL PATHWAY" FOR TISSUE DONATION: NEW DEFINITIONS FOR A COMMON AND SYSTEMATIC EUROPEAN APPROACH TO DECEASED DONOR TISSUE DONATION. Alberto Sandiumenge Received Received
  494-OP HOW DO SPANISH TRANSPLANT COORDINATORS APPROACH RELATIVES FOR CONSENT TO INTENSIVE CARE FOR ORGAN DONATION? RESULTS OF AN EMPIRICAL STUDY Rubén García-Sánchez Received Received
  495-OP ITALIAN SURVEY ON THE OPINIONS OF PROFESSIONALS FROM TRANSPLANT AND INTENSIVE CARE AREAS ABOUT COVID-19 AND SOLID ORGAN TRANSPLANTATION ACTIVITY Federica Galiandro Received Received
  496-OP APPLICATION OF THEORY OF PLANNED BEHAVIOR ON ORGAN DONATION BEHAVIOR: A SYSTEMATIC REVIEW Marzieh Latifi Received Received
  497-OP EUDONORGAN: A SUCCESSFUL TRAINING PROGRAM TO IMPROVE ORGAN DONATION KNOWLEDGE IN THE EUROPEAN UNION AND NEIGHBOURING COUNTRIES. Patricia Peralta Lasso Received Received
  498-OP CONDITIONS THAT INFLUENCE FAMILY CONSENT FOR INTENSIVE CARE FOR ORGAN DONATION: THE PERSPECTIVE OF SPANISH TRANSPLANT COORDINATORS Jorge S. López Received Received
  499-OP ENLIGHTENING YOUNG MINDS: A SMALL STEP IN THE CURRICULUM, A GIANT LEAP IN ORGAN DONATION - A SURVEY OF 996 RESPONDENTS ON ORGAN DONATION Abdul Rahman Hakeem Received Received
  500-OP SEIZING THE POTENTIAL RISK OF TRANSMISSION OF OLIGODENDROGLIOMA TO RECIPIENTS Serena Ammendola Received Received
  501-OP OUT-OF-HOSPITAL DONORS WITH IRREVERSIBLE CARDIAC ARREST IN RUSSIA: ONE OF THE PROMISING RECOURSE ACCORDING THE FIRST ST PETERSBURG EXPERIENCE Andrey Skvortsov Received Received
  502-OP WHAT HAPPENS TO UNSPECIFIED KIDNEY DONOR CANDIDATES WHO CANNOT PROCEED TO DONATE: AN INDUCTIVE THEMATIC ANALYSIS FROM THE BOUND STUDY Mira Zuchowski Received Received
  503-OP DECEASED DONOR TRANSPLANTATION DURING COVID TIMES - SUCCESS STORY FROM STATE IN INDIA. Maria Gomez Received Received
  504-OP NEW TECHNOLOGIES APPLIED TO MASTER EDUCATION IN THE TIME OF COVID-19 Chloe Balleste Received Received
  505-OP IMPACT OF THE SARS-COV-2 PANDEMIC ON TISSUE DONATION IN CATALONIA Belen Garcés Jimeno Received Received
  506-OP EFFECTS OF THE SARS-COV2 PANDEMIC ON ORGAN OFFERS IN EUROPE Federica Domini Received Received
  508-OP A NATIONAL SURVEY ON ENHANCED RECOVERY FOR RENAL TRANSPLANT RECIPIENTS: CURRENT PRACTICES AND TRENDS IN THE UNITED KINGDOM Carrie Scuffell Received Received
  509-OP ENHANCED RECOVERY AFTER SURGERY (ERAS) FOR RENAL TRANSPLANT RECIPIENTS: THE EARLY NEWCASTLE EXPERIENCE Carrie Scuffell Received Received
  510-OP POSITIVE IMPACT OF ERAS PROGRAMME ON LIVING AND DECEASED DONOR RENAL TRANSPLANT RECIPIENTS DURING COVID PANDEMIC Rachel Thomas Received Received
  511-OP FACTORS ASSOCIATED WITH PROLONGED LENGTH OF STAY FOLLOWING RENAL TRANSPLANTATION: A NURSE LED AUDIT Leigh Whinham Received Received
  514-OP TACROLIMUS MONOTHERAPY IN IMMUNOLOGICALLY LOW-RISK KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED-CONTROLLED TRIAL. Annelies De Weerd Received Received
  515-OP COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VS LCPT. Gionata Spagnoletti Received Received
  516-OP OUTCOMES OF IL2-RA INDUCTION THERAPY IN STANDARD-RISK RENAL TRANSPLANT RECIPIENTS MAINTAINED ON TACROLIMUS - A META-ANALYSIS Hatem Ali Received Received
  519-OP MESENCHYMAL STROMAL CELLS COMBINED WITH EVEROLIMUS PROMOTE T REG EXPANSION BUT DO NOT SYNERGIZE IN A RAT LIVER TRANSPLANT REJECTION MODEL Morgan Vandermeulen Received Received
  520-OP EFFICIENT EXPANSION OF HUMAN GRANZYME B–EXPRESSING B CELLS WITH POTENT REGULATORY PROPERTIES Hoa Mai Received Received
  521-OP GAMMA-DELTA T CELL THERAPY FOR THE TREATMENT OF POST-TRANSPLANT CMV INFECTION: PROOF OF CONCEPT Gabriel Marseres Received Received
  524-OP CHARACTERIZATION OF MESENCHYMAL STEM CELL INDUCED REGULATORY B CELLS (MSC-INDUCED BREG) Sergio G. Garcia Received Received
  700-OP MULTI-OMICS DATA INTEGRATION IN KIDNEY TRANSPLANTATION: THE HIDDEN PATHWAYS OF ANTIBODY-MEDIATED REJECTION Claire Tinel Received Received
  701-OP DEEP PHENOTYPING OF HUMAN KIDNEY TRANSPLANT REJECTION USING SINGLE-CELL TRANSCRIPTOMICS Baptiste Lamarthée Received Received
  702-OP REAL WORLD USE AND CLINICAL IMPACT OF EXTRACORPOREAL PHOTOPHERESIS IN HEART TRANSPLANT PATIENTS – RESULTS FROM A EUROPEAN MULTICENTER STUDY Markus J. Barten Received Received
  703-OP EPLETS INCOMPATIBILITY AS A DETERMINANT IN EXPOSURE TO TACROLIMUS Christian Córdoba Herrera Received Received
  713-OP DONATION AFTER CIRCULATORY DEATH (DCD) DONORS IN THE EMILIA-ROMAGNA REGION (ERR): OUR FIRST FORTY CASES Carlo De Cillia Received Received
  716-OP POST-VACCINE IMMUNITY TO COVID-19 VACCINE IN END-STAGE RENAL DISEASE PATIENTS AND KIDNEY TRANSPLANT RECIPIENT Magdalena Piotrowska Received Received
  717-OP ACUTE KIDNEY INJURY AFTER HEART TRANSPLANTATION: ROLE OF INTRAOPERATIVE MANAGEMENT Veronica Moriconi Received Received
  718-OP METABOLIC OUTCOMES AFTER PANCREAS TRANSPLANTATION FROM DONORS AFTER CIRCULATORY DEATH - THE UK REGISTRY ANALYSIS Jeevan Gopal Received Received
  719-OP PORTABLE GAMMA-CAMERA AS A USEFUL TOOL FOR BRAIN DEATH DIAGNOSIS José Moya Sánchez Received Received
  720-OP SPECIFIC URINARY METABOLOMIC PROFILE IN SPONTANEOUS TOLERANT KIDNEY TRANSPLANTED RECIPIENTS Luc Colas Received Received
  721-OP DESIGN OF STEADFAST STUDY EVALUATING TX200-TR101, A CHIMERIC ANTIGEN RECEPTOR T?REGULATORY CELL THERAPY FOR LIVING DONOR RENAL TRANSPLANT RECIPIENTS Emily Culme-Seymour Received Received
  722-OP EARLY SAFETY OF SARS-COV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS Michael Ou Received Received
  723-OP IDOTCOVID- INTERNATIONAL DATABASE ON ORGAN DONATION AND TRANSPLANTATION - COVID 19 Pedro Ventura-Aguiar Received Received
  724-OP LIMITED IMMUNOGENICITY OF A SINGLE DOSE OF SARS-COV-2 MRNA VACCINE IN SOLID ORGAN TRANSPLANT RECIPIENTS Brian Boyarsky Received Received
  725-OP SARS-COV 2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS Renato Pascale Received Received
  726-OP PROSPECTIVE EVALUATION OF HEALTH-RELATED QUALITY OF LIFE, UNCERTAINTY AND COPING STRATEGIES IN ORGAN TRANSPLANT RECIPIENTS DURING THE COVID PANDEMIC Angus Hann Received Received
  727-OP MOTIVATION, EXPERIENCES, AND MENTAL HEALTH OUTCOMES OF UNSPECIFIED KIDNEY DONORS IN THE NETHERLANDS: A QUALITATIVE STUDY Mathilde Pronk Received Received
  728-OP FIVE YEAR HEPATOCELLULAR CARCINOMA RECURRENCE WITH EVEROLIMUS PLUS REDUCED TACROLIMUS VS STANDARD TACROLIMUS AFTER LIVING-DONOR LIVER TRANSPLANTATION Gonzalo Sapisochin Received Received
  729-OP PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Reshma Rana Magar Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
01:23
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ESOT 2021 Recordings

 

Aug 29 - Sept 1, 2021 Milano
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 29/04/2021 TO 29/08/2022
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert